Physician profile
Ted Daniel Klein
NPI 1588930200
$18,189.57
in general payments reported to CMS, 2019-2025
49 companies · $4,429 in 2025
The $4,429 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,765 · 2020: $144 · 2021: $280 · 2022: $1,004 · 2023: $4,753 · 2024: $5,814 · 2025: $4,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,355 · Education: $4,350 · Travel and Lodging: $2,729 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,721 · Consulting Fee: $818 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,355.36 |
| Education | $4,349.99 |
| Travel and Lodging | $2,729.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,721.47 |
| Consulting Fee | $817.50 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,719.88 | 2022-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Ferring Pharmaceuticals INC. | $3,177.09 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $897.39 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Janssen Scientific Affairs, LLC | $817.50 | 2024 | |
| Baxter Healthcare | $570.26 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $389.39 | 2023-2025 | Gemtesa, Orgovyx |
| Neotract INC. | $358.85 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $353.39 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $352.59 | 2019-2023 | |
| Pfizer INC. | $290.97 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $281.58 | 2021-2025 | Lynparza, Keytruda, Welireg |
| Boston Scientific Corporation | $280.20 | 2019-2023 | |
| Urogen Pharma, INC. | $277.51 | 2021-2025 | Jelmyto |
| Medtronic, INC. | $234.48 | 2022-2024 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $195.14 | 2021-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $192.31 | 2021-2023 | Xiaflex, Aveed, Edex |
| Sun Pharmaceutical Industries INC. | $178.83 | 2019-2025 | Yonsa |
| Myriad Genetic Laboratories, INC. | $166.51 | 2024-2025 | Prolaris |
| Endo USA, INC. | $147.22 | 2024-2025 | Xiaflex, Aveed |
| Accord Healthcare, INC. | $144.61 | 2023-2025 | |
| Urovant Sciences INC | $138.99 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $120.25 | 2022-2025 | |
| Procept Biorobotics Corporation | $87.15 | 2024 | Aquabeam System |
| Antares Pharma, INC. | $84.92 | 2019-2025 | Xyosted |
| Blue Earth Diagnostics | $80.84 | 2019-2022 | |
| 180 Medical, INC. | $77.36 | 2024-2025 | Gentlecath Glide, Gentlecath |
| Myovant Sciences INC. | $72.45 | 2021-2022 | |
| Abbvie INC. | $69.40 | 2022-2024 | |
| Hollister Incorporated | $43.96 | 2021-2024 | |
| Verity Pharmaceuticals INC. | $35.55 | 2022-2024 | Trelstar |
| Laborie Medical Technologies Corp. | $33.66 | 2024-2025 | Endosheath Technology, Optilume Bph Drug Coated Balloon Catheter |
| Astrazeneca Pharmaceuticals LP | $31.76 | 2022-2024 | Lynparza |
| Cook Medical LLC | $31.23 | 2019 | |
| Olympus America INC. | $24.40 | 2023 | Itind System |
| Innovation Technologies INC | $23.11 | 2025 | Irrisept |
| Allergan, INC. | $22.00 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $20.64 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.41 | 2025 | |
| Photocure INC | $17.16 | 2019 | |
| Abc Home Medical Supply, INC. | $16.96 | 2024 | |
| Amgen INC. | $16.32 | 2022 | |
| Tolmar, INC. | $15.82 | 2025 | Jatenzo, Eligard |
| Mylan Institutional INC. | $15.04 | 2019 | |
| Progenics Pharmaceuticals, INC. | $14.87 | 2023 | Pylarify |
| Mission Pharmacal Company | $14.44 | 2022 | |
| Aytu Biopharma, INC. | $13.69 | 2019 | |
| Rochester Medical Corporation | $12.51 | 2020 | |
| Teleflex LLC | $11.98 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$14,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.